The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Guy M McKhannCreighton H Phelps


The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dement...Continue Reading


Nov 16, 2001·Archives of Neurology·G M McKhannUNKNOWN Work Group on Frontotemporal Dementia and Pick's Disease
Mar 11, 2004·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Alberto LleóBradley T Hyman
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Sep 28, 2007·Brain : a Journal of Neurology·S AlladiJ R Hodges
Dec 20, 2007·Alzheimer Disease and Associated Disorders·Katya RascovskyBruce M Miller
Jul 18, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Harald HampelKaj Blennow
Sep 20, 2008·Nature Reviews. Neuroscience·Lars Bertram, Rudolph E Tanzi
Nov 11, 2008·Annals of Neurology·Gil D RabinoviciMaria Luisa Gorno-Tempini
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Apr 8, 2010·Annals of Neurology·Gaël ChételatUNKNOWN Australian Imaging Biomarkers and Lifestyle Research Group
Jul 22, 2010·Brain : a Journal of Neurology·David DolanRichard J O'Brien
Feb 12, 2011·Brain : a Journal of Neurology·Gaël ChételatUNKNOWN Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group
Feb 18, 2011·Neurology·M L Gorno-TempiniM Grossman
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackCreighton H Phelps

❮ Previous
Next ❯


Aug 10, 2011·Archives of Neurology·Clifford R JackUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 5, 2012·Archives of Neurology·Lawrence S Honig
Jul 18, 2012·Archives of Neurology·Holly D SoaresUNKNOWN Biomarkers Consortium Alzheimer's Disease Plasma Proteomics Project
Sep 17, 2011·Der Nervenarzt·R ZimmermannP Lewczuk
May 12, 2012·Der Nervenarzt·U FiedlerJ Benninghoff
Jan 25, 2012·Analytical and Bioanalytical Chemistry·Pedro CarmonaAdolfo Toledano
Mar 9, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Victor L VillemagneChristopher C Rowe
May 30, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Javier ArbizuUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 2, 2013·European Radiology·Pervinder BhogalHans Rolf Jäger
Oct 1, 2011·Acta Neuropathologica·Sriram VennetiJohn Q Trojanowski
Apr 25, 2012·Acta Neuropathologica·Jon B ToledoJohn Q Trojanowski
Nov 10, 2012·Acta Neuropathologica·Lara WahlsterOksana Berezovska
Oct 9, 2013·Acta Neuropathologica·Clifford R JackVladimir Kepe
Oct 25, 2013·Acta Neuropathologica·William T HuJohn Q Trojanowski
Oct 1, 2013·European Archives of Psychiatry and Clinical Neuroscience·Dietmar Rudolf ThalAjeet Rijal Upadhaya
Jun 28, 2011·Journal of Neurology·Daniela Galimberti, Elio Scarpini
Oct 17, 2012·Journal of Neurology·Samantha GalluzziUNKNOWN Translational Outpatient Memory Clinic Working Group
Dec 18, 2012·Journal of Neurology·Federica AgostaMassimo Filippi
Jan 30, 2013·Journal of Neurology·Anahita AdeliKeith A Josephs
May 30, 2013·Journal of Neural Transmission·Philipp Mahlknecht, Werner Poewe
Dec 3, 2013·Inflammation·Domenico NuzzoMarta Di Carlo
Jan 31, 2013·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Shozo FurumotoYukitsuka Kudo
May 23, 2012·Brain Imaging and Behavior·Jeannine SkinnerUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jun 1, 2012·Brain Imaging and Behavior·S Duke HanUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 22, 2012·Brain Imaging and Behavior·Alden L GrossUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Oct 17, 2012·Brain Imaging and Behavior·Kwangsik NhoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative--ADNI
Jul 5, 2011·Current Neurology and Neuroscience Reports·Luis F Gonzalez-CuyarThomas J Montine
Aug 7, 2012·Current Neurology and Neuroscience Reports·Gladys E Maestre
Oct 19, 2013·Current Neurology and Neuroscience Reports·David A Wolk
Jul 10, 2012·Current Psychiatry Reports·Yonas E Geda
May 3, 2013·Current Psychiatry Reports·Abhisek C Khandai, Howard J Aizenstein
Dec 28, 2011·Molecular Neurobiology·Anders M Fjell, Kristine B Walhovd
Oct 24, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Chendhore S VeerappanGiovanni Coppola
Sep 20, 2011·International Psychogeriatrics·Mary Ganguli, Eric Rodriguez
Mar 17, 2012·International Psychogeriatrics·James T BeckerMary Ganguli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.